Physician profile
Russell Stanley
NPI 1639336746
$18,421.03
in general payments reported to CMS, 2019-2025
37 companies · $1,874 in 2025
The $1,874 reported for 2025 was more than what 82% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,816 · 2020: $869 · 2021: $4,389 · 2022: $1,836 · 2023: $4,675 · 2024: $2,962 · 2025: $1,874.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,824 · Travel and Lodging: $3,667 · Education: $20.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,824.49 |
| Travel and Lodging | $3,667.35 |
| Education | $20.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,432.56 | 2019-2025 | N/A, Asnis, Ortholoc 2 Lapifuse |
| Medinc of Texas | $2,412.23 | 2021-2022 | |
| Mylan Specialty L.P. | $2,295.55 | 2023 | |
| Paratek Pharmaceuticals, INC. | $1,404.99 | 2019-2025 | Nuzyra |
| Treace Medical Concepts, INC. | $1,184.13 | 2022-2025 | |
| Smith+Nephew, INC. | $1,173.50 | 2019-2025 | Grafix Pl, Collagenase Santyl, Stravix Pl |
| Organogenesis INC. | $881.02 | 2019-2025 | Puraply, Simplimax, Affinity |
| Mission Medical Distribution, LLC | $718.34 | 2023-2025 | |
| Arthrex, INC. | $600.30 | 2024 | |
| Kerecis Limited | $482.73 | 2019-2025 | Kerecis Omega3 Surgiclose, Kerecis Surgiclose, Kerecis Omega3 Marigen |
| Horizon Therapeutics Plc | $319.10 | 2019-2023 | Krystexxa |
| Medline Industries LP | $300.46 | 2022-2023 | |
| Trilliant Surgical LLC. | $199.94 | 2019-2020 | |
| Nevro Corp. | $195.34 | 2023 | Senza |
| Acera Surgical, INC. | $175.28 | 2019-2021 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $168.47 | 2021-2023 | Jublia |
| Bone Support INC. | $166.45 | 2025 | Cerament G, Ceramentbone Void Filler |
| Janssen Pharmaceuticals, INC | $156.32 | 2021 | |
| Wright Medical Technology, INC. | $138.42 | 2019-2020 | |
| Grt US Holding, INC. | $137.73 | 2022 | |
| Merck Sharp & Dohme LLC | $136.17 | 2019 | |
| Sebela Pharmaceuticals INC. | $134.67 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $94.69 | 2019 | |
| Nvision Biomedical Technologies, INC. | $92.24 | 2023 | Foot and Ankle |
| Integra Lifesciences Corporation | $61.39 | 2019-2020 | |
| Amgen INC. | $60.80 | 2024-2025 | Krystexxa |
| Melinta Therapeutics, LLC | $59.96 | 2019-2022 | |
| Medartis INC. | $51.53 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $34.96 | 2022-2023 | Seglentis |
| Medtronic, INC. | $29.93 | 2022 | |
| Kci USA, INC. | $28.76 | 2020 | |
| Hydrofera LLC | $20.23 | 2023 | Hydrofera Blue |
| Depuy Synthes Sales INC. | $20.01 | 2020 | |
| Avanos Medical | $16.40 | 2021 | |
| Zyla Life Sciences, INC. | $12.94 | 2019 | |
| Nabriva Therapeutics, Plc | $12.51 | 2021 | |
| Arthrosurface Incorporated | $10.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Russell Stanley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.